Patients with dementia had an increased prevalence of major depressive disorder.
Antipsychotic use was more common for off-label conditions in older adults, including for dementia, behavioral issues, cognitive deficiency, and use of physical restraint.
Patients who felt the situation was "abnormal" were less likely to seek help. This trend was more common in patients with Parkinson disease than patients with dementia, although both described feeling "embarrassed or ashamed."
A placebo-controlled study could further clarify these results and possibly strengthen the case for antidepressant treatment for depression in vascular cognitive impairment.
Intranasal esketamine in combination with oral antidepressants demonstrated significant reduction of depressive symptoms and improved overall severity of depressive illness and health-related quality of life and functioning.
Documentation of geriatric assessments during care transitions can be improved with a quality improvement intervention.
There is limited evidence for the benefits of different interventions to prevent late-life dementia.
Although existing management strategies for delirium are limited in effectiveness, researchers are hopeful that improvements in prevention strategies for delirium may be achieved by gaining a better understanding of the role of cognitive and brain reserve.
Results from animal studies have been showing that anesthetics may be neurotoxic and could lead to cognitive dysfunction.
The use of nursing homes is increasing for those who are cognitively impaired.
Antidepressants categorized as potentially inappropriate medication for elderly patients were associated with an increased risk of dementia.
Serum concentrations of second-generation antipsychotics were significantly higher in patients over the age of 70.
Traumatic brain injury is a significant burden on the US health system and is a contributing factor in one-third of all injury-related deaths.
Among older people with visual impairment, 57.2% are at risk for mild or moderate depression.
In older adults, life expectancy and delayed disability are associated with having a favorable behavioral profile.
Contrary to common belief, the prevalence of depression in older adults does not decrease with age.
Antidepressant treatment in combination with DMARDs and biologics led to the best positive dynamics of mental disorder frequency.
Shekhar Saxena, MD, director of the Department of Mental Health and Substance Abuse at the World Health Organization, speaks about depression.
Cognitively normal elderly individuals who engage in specific mentally stimulating activities have a decreased risk of mild cognitive impairment.
Research findings support continuation of ECT plus medication in a depressed elderly population.
Recognition of self-reported symptoms that may appear at early onset of amyloid accumulation, such as loneliness, point to opportunities for preventive therapies.
Findings suggest that efforts to encourage more planning aren't working.
Regular late-life volunteering is independently tied to decreased risk of cognitive impairment.
The American Heart Association issues a scientific statement on the possible link between chronic arterial hypertension and cognition.
In 2016, an estimated 5.4 million US adults have Alzheimer disease.
The extent or severity of physical ailments and functional impairment needs to be carefully examined in order to successfully prevent suicide in late life.
Dementia risk was particularly elevated in patients with depression who had higher scores on cognitive tests at baseline.
Researchers examine age-related alterations in memory.
To date, there are no validated biomarkers to independently assess Parkinson Disease diagnosis and prognosis, or to measure disease severity.
Interventions are needed to enhance adherence to prescribed medications, especially in older adults experiencing new episodes of depression.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- Insomnia in Borderline Personality Disorder May Increase Suicide Risk
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression